FDA Commissioner's Resignation Offers Chance to Review Mail-Order Abortion Drugs

The resignation of FDA Commissioner Dr. Marty Makary creates an opportunity for the agency to return to its mission of protecting the public by ensuring drugs are safe. Whether Kyle Diamantas is running the agency long-term or the administration expediently appoints someone new, now is the time to address the most significant public health crisis ...